Holen Sie sich die Stockscreener-App
1.08
0.00%
0.00
Vorhandelsmarkt:
1.08
Schlusskurs vom Vortag:
$1.08
Offen:
$1.085
24-Stunden-Volumen:
380.05K
Relative Volume:
0.80
Marktkapitalisierung:
$25.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.33M
KGV:
-1.6364
EPS:
-0.66
Netto-Cashflow:
$-13.21M
1W Leistung:
+2.86%
1M Leistung:
-3.74%
6M Leistung:
+8.00%
1J Leistung:
-10.00%
1-Tages-Spanne:
$1.0646
$1.11
1-Wochen-Bereich:
$0.98
$1.15
52-Wochen-Spanne:
$0.8101
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Firmenname
Enlivex Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ENLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.08 | 29.81M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.65 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
708.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.91 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-02 | Bestätigt | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Aktie (ENLV) Neueste Nachrichten
Published on: 2025-08-26 20:48:16 - Newser
How moving averages guide Enlivex Therapeutics Ltd. tradingLong Setup & Weekly Market Pulse Alerts - Newser
How to build a dashboard for Enlivex Therapeutics Ltd. stockWeekly Profit Summary & AI Optimized Trade Strategies - Newser
Is it time to cut losses on Enlivex Therapeutics Ltd.July 2025 Reactions & Safe Capital Preservation Plans - Newser
Relative strength of Enlivex Therapeutics Ltd. in sector analysisMarket Sentiment Review & Free Safe Entry Trade Signal Reports - Newser
What high frequency data says about Enlivex Therapeutics Ltd.2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser
Quantitative breakdown of Enlivex Therapeutics Ltd. recent moveBull Run & Verified Stock Trade Ideas - Newser
Published on: 2025-08-26 05:45:48 - Newser
Real time pattern detection on Enlivex Therapeutics Ltd. stock2025 Big Picture & Safe Entry Momentum Tips - Newser
Using data filters to optimize entry into Enlivex Therapeutics Ltd.July 2025 Sector Moves & Fast Entry and Exit Trade Plans - Newser
Is Enlivex Therapeutics Ltd. stock bottoming outQuarterly Trade Review & Daily Risk Controlled Trade Plans - Newser
Published on: 2025-08-25 05:10:06 - Newser
Developing predictive dashboards with Enlivex Therapeutics Ltd. dataVolume Spike & Daily Volume Surge Signals - Newser
Key metrics from Enlivex Therapeutics Ltd.’s quarterly dataWeekly Gains Summary & Smart Investment Allocation Tips - Newser
Using Python tools to backtest Enlivex Therapeutics Ltd. strategiesWeekly Trade Summary & AI Powered Buy and Sell Recommendations - Newser
How to manage a losing position in Enlivex Therapeutics Ltd.2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Is Enlivex Therapeutics Ltd. building a consolidation baseQuarterly Performance Summary & Daily Chart Pattern Signals - Newser
Update Recap: Is Enlivex Therapeutics Ltd. benefiting from interest rate changesWeekly Volume Report & Risk Managed Investment Signals - sundaytimes.kr
Is Enlivex Therapeutics Ltd.’s ROE strong enough2025 Stock Rankings & Entry Point Confirmation Alerts - theviewers.co.kr
What earnings revisions data tells us about Enlivex Therapeutics Ltd.Trade Volume Summary & Real-Time Buy Zone Alerts - Newser
Key resistance and support levels for Enlivex Therapeutics Ltd.Volume Spike & AI Driven Price Forecasts - Newser
Enlivex Therapeutics (ENLV) Rating Maintained as Buy by D. Boral Capital | ENLV Stock News - GuruFocus
Enlivex Therapeutics (ENLV) Expected to Announce Earnings on Friday - Defense World
Is Enlivex Therapeutics Ltd. a stock for growth or value investors2025 EndofYear Setup & Growth Focused Investment Plans - theviewers.co.kr
Enlivex Therapeutics Ltd. Could See a Relief Rally From SupportJuly 2025 Outlook & Reliable Breakout Stock Forecasts - newsyoung.net
Is Enlivex Therapeutics Ltd. showing signs of accumulationEarnings Growth Report & Safe Capital Growth Tips - Newser
Enlivex Therapeutics shares rise 1.90% after-hours following a special call event. - AInvest
Enlivex Therapeutics shares fall 14.40% intraday after a special call with RedChip Companies. - AInvest
What indicators show strength in Enlivex Therapeutics Ltd.Market Risk Analysis & Safe Entry Zone Tips - Newser
Risk vs reward if holding onto Enlivex Therapeutics Ltd.July 2025 Macro Moves & Intraday High Probability Alerts - Newser
Enlivex Therapeutics (NASDAQ:ENLV) Receives Buy Rating from D. Boral Capital - Defense World
Enlivex advances lead cell therapy to Phase IIb in osteoarthritis - Yahoo Finance
Finanzdaten der Enlivex Therapeutics Ltd-Aktie (ENLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):